ENDONOVO THERAPEUTICS, INC. (ENDV) Net margin 2013–2022
ENDONOVO THERAPEUTICS, INC. (ENDV) net profit margin by fiscal year — reported net income divided by reported revenue.
-13649.2%FY2022 · since FY2013: -12634.5% → -13649.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -13649.2% | -9402.0 pp |
| FY2021 | -4247.2% | -4008.6 pp |
| FY2020 | -238.6% | +5343.8 pp |
| FY2019 | -5582.4% | +2147.2 pp |
| FY2018 | -7729.5% | — |
| FY2015 | -158633.9% | -154667.7 pp |
| FY2014 | -3966.2% | +8668.3 pp |
| FY2013 | -12634.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice